» Articles » PMID: 11603921

Decreased Expression of Insulin-like Growth Factor-1 and Apoptosis of Vascular Smooth Muscle Cells in Human Atherosclerotic Plaque

Overview
Date 2001 Oct 18
PMID 11603921
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin-like growth factor-1 (IGF-1) plays an important role in migration, cell cycle progression and survival of vascular smooth muscle cells (VSMC). We investigated the specific localization of IGF-1 and its receptor (IGF-1R) and their association with apoptosis and the expression of apoptosis-related proteins in early and advanced atherosclerotic lesions. Human atherosclerotic plaques (n=23) from patients undergoing aortic, carotid or femoral arterial surgery were studied. Immunohistochemistry and in situ hybridization revealed significantly higher expression of IGF-1 and IGF-1R in the media than in the intima of early atherosclerotic lesions (P<0.01). Medial VSMC positive for BAX, a proapoptotic protein of the B-cell CLL/lymphoma 2 (BCL2) family, showed colocalization of IGF-1. Apoptosis, as detected by DNA in situ terminal deoxynucleotidyl transferase end labeling (TUNEL), was not present in these early lesions. In advanced atherosclerotic plaques, the expression of IGF-1 and IGF-1R was significantly lower in the intimal regions with macrophage infiltration than in those without macrophage infiltration or than in the media (P<0.01). Furthermore, IGF-1 and IGF-1R immunoreactivity was markedly lower in intimal TUNEL-positive VSMC compared with intimal BAX-positive and medial VSMC (P<0.01). We conclude that IGF-1 and IGF-1R expression are reduced in the deep intima of early atherosclerotic lesions and in areas of advanced plaques with macrophage infiltration. Since IGF-1 is a potent survival factor for VSMC, poor expression of IGF-1 and IGF-1R in intimal regions with macrophage infiltration would likely contribute to triggering VSMC apoptosis potentially leading to plaque weakening, plaque rupture and acute coronary events.

Citing Articles

Insulin-like growth factor 1 reduces coronary atherosclerosis in pigs with familial hypercholesterolemia.

Sukhanov S, Higashi Y, Yoshida T, Danchuk S, Alfortish M, Goodchild T JCI Insight. 2023; 8(4).

PMID: 36602878 PMC: 9990768. DOI: 10.1172/jci.insight.165713.


Association between insulin-like growth factor-1 and cardiovascular events: a systematic review and dose-response meta-analysis of cohort studies.

Li T, Zhao Y, Yang X, Feng Y, Li Y, Wu Y J Endocrinol Invest. 2022; 45(12):2221-2231.

PMID: 35596917 DOI: 10.1007/s40618-022-01819-1.


Vascular dysfunction as a potential culprit of sarcopenia.

Jeon Y, Shin M, Saini S, Custodero C, Aggarwal M, Anton S Exp Gerontol. 2020; 145:111220.

PMID: 33373710 PMC: 8168450. DOI: 10.1016/j.exger.2020.111220.


MiR-197-3p regulates endothelial cell proliferation and migration by targeting IGF1R and BCL2 in Kawasaki disease.

Li Y, Wu X, Gao F, Wang X Int J Clin Exp Pathol. 2020; 12(11):4181-4192.

PMID: 31933818 PMC: 6949791.


The role of exercise in the reversal of IGF-1 deficiencies in microvascular rarefaction and hypertension.

Norling A, Gerstenecker A, Buford T, Khan B, Oparil S, Lazar R Geroscience. 2019; 42(1):141-158.

PMID: 31808026 PMC: 7031491. DOI: 10.1007/s11357-019-00139-2.